20 June 2014

The Development of Novel Biologics and Serosurveillance Studies of Emerging and Zoonotic Viruses

Organised by:

SCI's Biotechnology Group in conjunction with the University of Westminster

University of Westminster, 115 New Cavendish Street, London W1W 6UW

Registration Closed

This event is no longer available for registration.

The study of highly pathogenic viruses is limited by the need for biosafety level 3 or 4 laboratories to handle wild type viruses. Using pseudotyping technology overcomes this and also has several other advantages over using wild type virus. We successfully pseudotyped isolates from each lyssavirus species allowing us to study the antigenic properties of the viral glycoproteins, develop novel therapeutics against the protoype species, rabies virus, and undertake serosurveillence studies to further our understanding of the public health threat these viruses pose. We are currently expanding this technology to include other emerging, zoonotic viruses.
Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

Venue and Contact

University of Westminster

School of Life Sciences,115 New Cavendish Street London W1W 6UW

Conference Team

+44 (0)20 7598 1561

Email: Communications@soci.org


This is a free event, no need to book.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com


Additional Info


Prof Kieran Clarke, Department of Physiology, Anatomy & Genetics, University of Oxford